[This Week's IPO] Book-Building and Subscription Schedule for the Fourth Week of April

In the fourth week of this month (April), DN Solutions, ImmunOncia, BioVisu, Link Solution, and Lotte Global Logistics will conduct book-building for institutional investors. Rokit Healthcare, Wonil TNI, Now Robotics, and Organoid Science are preparing for their public subscription rounds.

◆DN Solutions = DN Solutions, which began in 1976 as the machine tool division of Daewoo Heavy Industries, is Korea's leading machine tool manufacturer by revenue and ranks third globally. In 2022, DN Group acquired the company from MBK Partners and changed its name from Doosan Machine Tools to DN Solutions.

Of the total 17,537,000 shares offered, 7,576,594 shares (43.2%) are newly issued, and 9,960,406 shares (56.8%) are existing shares being sold. The expected offering price is between 65,000 and 89,700 KRW per share. Book-building for institutional investors will take place from April 22 to 28, and the public subscription will be held on May 7 and 8. The lead managers are Mirae Asset Securities, Samsung Securities, UBS Securities, Korea Investment & Securities, and Merrill Lynch Securities.

◆ImmunOncia = Founded in 2016, ImmunOncia is a company specializing in immuno-oncology, with its largest shareholder being Yuhan Corporation (67%). Its main pipeline includes the immuno-oncology drugs 'IMC-001' and 'IMC-002'. IMC-001 is currently in Phase 2 clinical trials in Korea, while IMC-002 is in Phase 1b clinical trials domestically. The company also possesses several other new drug candidates.

The total offering consists of 9,140,482 shares, all of which are existing shares. The expected offering price is between 3,000 and 3,600 KRW per share, with a total offering amount of 27.4 billion KRW. Book-building for institutional investors will be conducted from April 22 to 28, followed by the public subscription on May 7 and 8. The lead manager is Korea Investment & Securities.

◆BioVisu = Established in 2018, BioVisu develops, manufactures, and sells a variety of medical aesthetic products, including skin boosters and HA fillers. Its main brands include ▲Candorup ▲Acenart ▲Corena, with each brand's key products utilizing hyaluronic acid cross-linking technology to maximize durability and efficacy.

The company plans to offer a total of 3,000,000 shares (100% newly issued). The expected offering price is between 8,000 and 9,100 KRW per share. The total offering size is between 24 billion and 27.3 billion KRW, and the post-listing market capitalization is projected to reach between 120.4 billion and 136.9 billion KRW. Book-building will be conducted for five days from April 23 to 29 for domestic and overseas institutional investors, and the public subscription will take place on May 8 and 9. The lead manager is Daishin Securities.

◆Link Solution = Founded in 2015, Link Solution is a 3D printing company that develops and sells 3D printer equipment and provides customized 3D printing services, offering a differentiated one-stop solution. The company is contributing to the transition from traditional manufacturing to smart automated manufacturing based on its high-precision, high-speed printing technology and a platform with excellent material compatibility.

A total of 900,000 shares will be offered. The expected offering price is between 20,000 and 23,000 KRW per share. Book-building will be conducted for five days from April 24 to 30, followed by the public subscription on May 12 and 13. The company aims to list on KOSDAQ within the year. The lead manager is Shin Young Securities.

◆Lotte Global Logistics = Lotte Global Logistics, a member of the Lotte Group, is a global comprehensive logistics company engaged in parcel delivery, supply chain management (SCM), and global logistics. Domestically, it provides fast and accurate customized logistics services through advanced logistics infrastructure such as the Jincheon 'Central Region Mega Hub Terminal,' established in January 2022.

The total number of shares offered is 14,944,322. The expected offering price per share ranges from 11,500 to 13,500 KRW, with the total offering amount projected at 201.7 billion KRW based on the upper end of the price band. Book-building for institutional investors will take place from April 24 to 30 to determine the final offering price, and the public subscription will be held on May 12 and 13. The lead managers are Korea Investment & Securities and Samsung Securities, with KB Securities as the co-manager.

◆Rokit Healthcare = The expected offering price is between 11,000 and 13,000 KRW per share. Book-building for institutional investors was conducted from April 14 to 18, and the public subscription will take place on April 23 and 24. The lead managers are SK Securities and KB Securities.

Rokit Healthcare develops and supplies advanced regenerative medical solutions for diabetic foot treatment, skin regeneration, cartilage regeneration, and kidney regeneration, based on its unique 'AI ultra-personalized organ regeneration platform' technology. By utilizing artificial intelligence software and medical 3D bioprinters, the company produces customized patches or organs for patients to aid in treatment.

◆Wonil TNI = The expected offering price range is 11,500 to 13,500 KRW per share. Book-building will be conducted until April 22, followed by the public subscription on April 24 and 25. The lead manager is NH Investment & Securities.

Wonil TNI is a company that supplies various products by localizing core technologies in eco-friendly energy sectors such as hydrogen, LNG, and nuclear power. Since its establishment in 1998, Wonil TNI has grown based on its gas equipment business, expanded into nuclear and LNG businesses in the early 2000s, and entered the hydrogen business around 2020 in response to changes in the energy paradigm.

◆Now Robotics = The expected offering price band is 5,900 to 6,800 KRW per share. The total offering size is between 14.7 billion and 17 billion KRW. Book-building for institutional investors was conducted from April 14 to 18, and the public subscription will be held on April 24 and 25. The lead manager is Daishin Securities, with IM Securities as the co-manager.

Founded in 2016, Now Robotics is a company specializing in intelligent robots and offers a comprehensive lineup of industrial robots, including ▲take-out robots ▲Cartesian robots ▲multi-joint robots ▲SCARA robots, as well as autonomous logistics robots for various industries.

◆Organoid Science = The expected offering price band is 17,000 to 21,000 KRW per share. Book-building for institutional investors will be conducted for five business days until April 22 to determine the final offering price, followed by the public subscription from April 25 to 28, after which the company will be listed. The lead manager is Korea Investment & Securities.

Established in 2018, Organoid Science is engaged in developing treatments for intractable diseases using 'organoid' technology, which recreates human organs by culturing stem cells in three dimensions. Organoids exhibit excellent regenerative capabilities when transplanted into damaged tissues and, due to their high degree of similarity to human organs, are widely used as models for evaluating the efficacy of new drugs, health functional foods, and cosmetics.